Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

6825 ARTÍCULOS , VIENDO DEL 1141 AL 1155

Sex Differences in Alzheimer's Disease

Aggarwal NT, Mielke MM.

Neurol Clin. 2023 May;41(2):343-358. doi: 10.1016/j.ncl.2023.01.001.

Vascular dementia subtypes, pathophysiology, genetics, neuroimaging, biomarkers, and treatment updates along with its association with Alzheimer's dementia and diabetes mellitus

Prajjwal P, Marsool MDM, Inban P, Sharma B, Asharaf S, Aleti S, Gadam S, Al Sakini AS, Hadi DD.

Dis Mon. 2023 May;69(5):101557. doi: 10.1016/j.disamonth.2023.101557. Epub 2023 Apr 6.

Meta-analysis of published cerebrospinal fluid proteomics data identifies and validates metabolic enzyme panel as Alzheimer's disease biomarkers

van Zalm PW, Ahmed S, Fatou B, Schreiber R, Barnaby O, Boxer A, Zetterberg H, Steen JA, Steen H.

Cell Rep Med. 2023 Apr 18;4(4):101005. doi: 10.1016/j.xcrm.2023.101005.

Association of the Informant-Reported Memory Decline With Cognitive and Brain Deterioration Through the Alzheimer Clinical Continuum

Kuhn E, Perrotin A, La Joie R, Touron E, Dautricourt S, Vanhoutte M, Vivien D, de La Sayette V, Chételat G; Alzheimer's Disease Neuroimaging Initiative.

Neurology. 2023 Jun 13;100(24):e2454-e2465. doi: 10.1212/WNL.0000000000207338. Epub 2023 Apr 21.

Methodological flaws in"diagnostic accuracy of blood biomarkers for Alzheimer's disease and amnestic mild cognitive impairment: A meta-analysis"

Hsu YP, Hsu CW, Chen LF, Liu YK.

Ageing Res Rev. 2023 Jul;88:101938. doi: 10.1016/j.arr.2023.101938. Epub 2023 Apr 23.

Research diagnostic criteria for mild cognitive impairment with Lewy bodies: A systematic review and meta-analysis

Donaghy PC, Carrarini C, Ferreira D, Habich A, Aarsland D, Babiloni C, Bayram E, Kane JP, Lewis SJ, Pilotto A, Thomas AJ, Bonanni L; Alzheimer's Association International Society to Advance Alzheimer's Research and Treatment Lewy Body Dementias Prodromal Working Group.

Alzheimers Dement. 2023 Jul;19(7):3186-3202. doi: 10.1002/alz.13105. Epub 2023 Apr 24.

Evolution of Detecting Early Onset of Alzheimer's Disease: From Neuroimaging to Optical Immunoassays

Hsiao WW, Angela S, Le TN, Ku CC, Hu PS, Chiang WH.

J Alzheimers Dis. 2023;93(3):821-845. doi: 10.3233/JAD-221202.

Advances and applications of fluids biomarkers in diagnosis and therapeutic targets of Alzheimer's disease

Xu Y, Jiang H, Zhu B, Cao M, Feng T, Sun Z, Du G, Zhao Z.

CNS Neurosci Ther. 2023 Aug;29(8):2060-2073. doi: 10.1111/cns.14238. Epub 2023 May 5.

Assessing adipokines as potential biomarkers of dementia, Alzheimer's disease, and mild cognitive impairment: A systematic review and meta-analysis

García-García I, Fernández-Andújar M, Narváez M, García-Casares N.

Obes Rev. 2023 Aug;24(8):e13573. doi: 10.1111/obr.13573. Epub 2023 May 10.

GFAP as a Potential Biomarker for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Kim KY, Shin KY, Chang KA.

Cells. 2023 May 4;12(9):1309. doi: 10.3390/cells12091309.

Revolutionizing the Early Detection of Alzheimer's Disease through Non-Invasive Biomarkers: The Role of Artificial Intelligence and Deep Learning

Vrahatis AG, Skolariki K, Krokidis MG, Lazaros K, Exarchos TP, Vlamos P.

Sensors (Basel). 2023 Apr 22;23(9):4184. doi: 10.3390/s23094184.

Utility of Blood-Based Tau Biomarkers for Mild Cognitive Impairment and Alzheimer's Disease: Systematic Review and Meta-Analysis

Zabala-Findlay A, Penny LK, Lofthouse RA, Porter AJ, Palliyil S, Harrington CR, Wischik CM, Arastoo M.

Cells. 2023 Apr 18;12(8):1184. doi: 10.3390/cells12081184.

Blood biomarkers for Alzheimer's disease in clinical practice and trials

Hansson O, Blennow K, Zetterberg H, Dage J.

Nat Aging. 2023 May;3(5):506-519. doi: 10.1038/s43587-023-00403-3. Epub 2023 May 18.

Detection and treatment of Alzheimer's disease in its preclinical stage

Rafii MS, Aisen PS.

Nat Aging. 2023 May;3(5):520-531. doi: 10.1038/s43587-023-00410-4. Epub 2023 May 18.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias